Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Comprehensive Cancer Network (NCCN) is a non-profit alliance of 33 leading cancer centers in the United States dedicated to patient care, research, and education. It is most recognized for developing the NCCN Clinical Practice Guidelines in Oncology, which serve as the standard for clinical policy and drug utilization in the oncology community. These guidelines are used extensively by clinicians, payers, and pharmaceutical companies to guide treatment decisions and reimbursement. NCCN also facilitates oncology research through its Oncology Research Program and provides continuing medical education for healthcare professionals. By maintaining a Corporate Council, NCCN engages with major biotechnology and pharmaceutical firms to discuss trends in cancer care and policy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Comprehensive Cancer Center.